SLCH Consortium Ophthalmology

Topics

• Glaucoma and retinal disorders 530
• Retinal Diseases and Treatments 362
• Corneal surgery and disorders 232
• Ophthalmology and Visual Impairment Studies 168
• Retinal Development and Disorders 166
• Ocular Diseases and Behçet’s Syndrome 165
• Ocular Oncology and Treatments 156
• Retinal and Macular Surgery 153
• Ocular Infections and Treatments 117
• Retinal Imaging and Analysis 114
• Ophthalmology and Eye Disorders 112
• Intraocular Surgery and Lenses 101

Most cited

1. A foundation model for generalizable disease detection from retinal images.

   Nature · 2023 · 587 citations · Aaron Y Lee

2. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.

   Lancet (London, England) · 2022 · 670 citations · Hugh Lin

3. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.

   Ophthalmology · 2024 · 192 citations · Hugh Lin

4. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.

   Lancet (London, England) · 2022 · 396 citations · Hugh Lin

5. Prevalence of Diabetic Retinopathy in the US in 2021.

   JAMA ophthalmology · 2023 · 219 citations · Aaron Y Lee

6. Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study.

   Ophthalmology · 2024 · 71 citations · Brian Flowers